Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01696994 · ClinicalTrials.gov registry record · NA
Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)
A NA study of Ovarian Carcinoma and Ovarian Germ Cell Tumor, sponsored by National Cancer Institute (NCI).
- Active
- Registry status
- NA
- Development phase
- 78,216
- Enrollment target
- 1
- Study location
NCT01696994 is a NA study of Ovarian Carcinoma and Ovarian Germ Cell Tumor that is active but no longer recruiting, run by National Cancer Institute (NCI). The registered enrollment target is 78,216 participants, above the 1,009-participant average among 35 other Ovarian Carcinoma trials with a reported enrollment target (7652% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01696994, a NA study of Ovarian Carcinoma and Ovarian Germ Cell Tumor, is active but no longer recruiting, sponsored by National Cancer Institute (NCI).
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 78,216 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial studies whether screening methods used to diagnose cancer of the prostate, lung, colon, rectum, or ovaries can reduce deaths from these cancers. Screening tests may help doctors find cancer cells early and plan better treatment for ovarian cancer. The ovarian cancer screening tests are part of a trial that addresses the screening of four cancer sites, each with their own results record: prostate (NCT00002540), lung (NCT01696968), colorectal (NCT01696981), and ovarian (NCT01696994).
Conditions Studied
Interventions
- OTHER Laboratory Biomarker Analysis
- PROCEDURE Ultrasound Imaging
- OTHER Screening Questionnaire Administration
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78,216 participants |
| Start Date | 1993-11-16 |
| Est. Completion | 2026-03-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01696994
The ClinicalTrials.gov registry entry for NCT01696994 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 78,216 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,009-participant average among 35 other Ovarian Carcinoma trials with a reported enrollment target (7652% higher). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Ovarian Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT01696994 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01696994 about?
NCT01696994 is a clinical study titled "Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)". This clinical trial studies whether screening methods used to diagnose cancer of the prostate, lung, colon, rectum, or ovaries can reduce deaths from these cancers. Screening tests may help doctors find cancer cells early and plan better treatment for ovarian cancer. The ovarian cancer screening tes...
What is the current status of trial NCT01696994?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 78,216 participants. The study started on 1993-11-16. Estimated completion is 2026-03-25.
What conditions does trial NCT01696994 study?
This clinical trial studies the following conditions: Ovarian Carcinoma, Ovarian Germ Cell Tumor.
What interventions are being tested in trial NCT01696994?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Ultrasound Imaging (PROCEDURE), Screening Questionnaire Administration (OTHER).
Who is sponsoring clinical trial NCT01696994?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01696994 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ovarian Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer
RECRUITING · NA
-
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
RECRUITING · NA
-
Ultrasound Microvessel Imaging for the Evaluation of Ovarian and Adnexal Lesions
RECRUITING · NA
-
Access to Genetic Testing in Underserved Patients With Cancer
RECRUITING · NA
-
The Vanguard Study: Testing a New Way to Screen for Cancer
RECRUITING · NA
-
Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.